ASRM 75th Scientific Congress & Expo

ASRM SCIENTIFIC SESSIONS, ROUNDTABLES AND ABSTRACTS

ABB/PEER has tentatively approved ASRM’s educational program scheduled for Monday, October 14, through Wednesday, October 16, for up to an estimated total of 10 contact hours. The calculation of contact hours is based on published programs that have been approved to date.

ASRM has not yet published a list of abstracts. When that information is available, ABB will review the list and make a final determination on the total contact hours approved for the overall program, including abstracts. The information will be announced and sample ABB/PEER CE forms for Monday/Tuesday/Wednesday will be posted on the website.

Scientific sessions and roundtables that have been pre-approved by ABB/PEER for continuing education credit appear below (by day):

Tuesday, October 15, 2019 – Scientific Sessions and Roundtables

• PLT01 Plenary 3: Is Human Germline Editing Ethical?
• PLT02 Plenary 4: Planned Oocyte Cryopreservation: A Patient's Perspective
• LET01 Pre-Plenary Special Session: Eye on AI: Artificial Intelligence in ART
• EET01 Human Genome Editing: Roles and Responsibilities of Fertility Clinics
• RTT3 Expanded versus targeted genetic testing before pregnancy: discussion of guidelines, options, and cost effectiveness
• RTT11 Fertility Preservation for the Transgender Patient
• RTT12 Direct To Consumer (DTC) Genetic Testing: Exploring the benefits, limitations and what to do when a patient brings results to the clinic
• RTT15 HIPAA risk assessment: Hand-on help for the administrator.
• RTT17 Patient-centered approach to azoospermia: choosing the best technique for sperm retrieval.
• RTT18 Is there a role for testosterone use in women?
• RTT24 Prospect for Non Invasive PGT
• RTT25 Detection of Mosaicism and Segmental Variations
• RTT26 Assisted Reproductive Technology (ART) laboratory networks/mergers: Do they improve outcome?
• RTT27 TESE for male factor infertility patient who can ejaculate (oligozoospermia or oligoasthenozoospermia or oligoteratozoospermia): Where is the evidence?
• RTT29 The Ethics of Baby Making in the Age of CRISPR
• RTT31 Hippa Headaches and ways to avoid them
• INT02 Mosaicism Exposed – How to Handle Mosaic Embryos
• INT05 Home Sperm Testing: What is Available, Limitations and Opportunities
• INT07 Debate: Measuring AMH: A useful investigation in Recurrent Early Pregnancy Loss?
• SYT03 Quality Management in Human ART: Time to Revisit the Issues
• SYT06 Fertility Trajectory of Klinefelter Syndrome: From Childhood, Adolescence to Adulthood
• SYT09 ALMER Symposium: Management of mosaic embryos after PGT-A in ART
• SYT10 Oocyte maturation in vitro and female fertility preservation
• SYT11 FDA Symposium: Reproductive HCT/P Donor Eligibility and Compliance Update for Reproductive HCT/P Establishments
• SYT12 World Health Organization (WHO) Symposium: Global Call to Action to Enhance Infertility Care (a non-CME symposium)

Click Below to View a Different Day:

• Saturday, October 12, 2019 – Pre-Congress Courses
• Sunday, October 13, 2019 – Pre-Congress Courses
• Monday, October 14, 2019 – ABB/PEER-approved Scientific Sessions & Roundtables
• Wednesday, October 16, 2019 – ABB/PEER-approved Scientific Sessions & Roundtables

QUESTIONS? CONTACT:

ABB Telephone: (314)241-1445, Email: abb@abbcert.org

AAB/CRB Telephone: (314)241-1445, Email: aab@aab.org or crb-aab@aab.org